Lumexa Imaging Holdings, Inc. Common Stock

NASDAQ:LMRI

Medical - Devices

Healthcare
$14.01 +7.25%

+$0.84 today

Market cap
$1.35B
Beta
2.18
P/E (TTM)
-34.3
EPS (TTM)
-$0.28
52W Low $6.45High $19.45

Volume 0.26M

Average 0.92M

LMRI Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

Lumexa Imaging Holdings, Inc. Common StockNASDAQ: LMRI

Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026

Depreciation & amortization of $14.04M in Q1 FY2026

Q1 FY2026 depreciation & amortization was $14.04M.

Context

  • Depreciation & amortization amounted to 5.4% of revenue in FY2025, down 0.6 pp from a year earlier.
  • Depreciation & amortization increased in 0 of the last 2 fiscal years.
  • FY2025 was the lowest annual figure in the 3 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$14.04M+13.3% QoQ
Last fiscal yearDec 2025
$55.39M-3.1% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-3.1%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the income statement

Latest · FY2025
55.39M USD
Year-over-year change
-3.1%
2-year CAGR
-12.4%

Depreciation & Amortization vs competitors

How LMRI compares with its peers on the latest reported figures

  • LMRI's FY2025 depreciation & amortization of $55.39M is the lowest of the 2 companies compared; the peer median is $178.36M.
  • Its year-over-year change of -3.1% is the highest of 2, against a peer median of -14.2%.
  • Depreciation & amortization amounts to 5.4% of revenue for LMRI, versus a peer median of 7.5%.
LMRI Competitors Peer median
Depreciation & Amortization for LMRI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
RDNTRadNet, Inc.LTM Sep 2026$178.36M -14.2%-6.3%7.5%
LMRILumexa Imaging Holdings, Inc. Common StockFY2025$55.39M -3.1%—5.4%
Peer median (excluding LMRI) $178.36M-14.2%-6.3%7.5%

Competitors are the stored peer set for LMRI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue935.93M948.87M1.02B
Cost of Revenue836.96M852.61M905.9M
Gross Profit98.97M96.26M117.19M
Gross Margin10.6%10.1%11.5%
Research & Development000
Selling, General & Admin55.17M70.36M90.45M
Operating Expenses76.52M41.02M90.45M
Depreciation & Amortization72.14M57.16M55.39M
EBITDA94.58M114M141.71M
EBITDA Margin10.1%12.0%13.9%
Operating Income22.45M55.24M26.73M
Operating Margin2.4%5.8%2.6%
Interest Income000
Interest Expense141.69M136.03M118.54M
Other Income / Expenses(141.69M)(134.44M)(58.95M)
Income Before Tax(119.25M)(79.19M)(32.22M)
Pre-Tax Margin-12.7%-8.3%-3.1%
Income Tax Expense2.98M14.91M14.89M
Net Income(122.23M)(94.1M)(47.1M)
Net Margin-13.1%-9.9%-4.6%
EPS (Basic)(1.29)(1.00)(0.66)
EPS (Diluted)(1.29)(1.00)(0.66)
Weighted Avg Shares94.57M94.57M70.98M
Weighted Avg Shares (Diluted)94.57M94.57M70.98M

Lumexa Imaging Holdings, Inc. Common Stock

NASDAQ:LMRI

Intrinsic Alpha fair value

Locked

Current Price

$14.01

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.